In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 2, 2008, Pages 210-215

  Seral, Cristina ^a   Suárez, Laura ^b   Rubio Calvo, Carmen ^a   Gómez Lus, Rafael ^b   Gimeno, Mercedes ^c   Coronel, Pilar ^c   Durán, Estrella ^a   Becerril, Raquel ^b   Oca, Mercedes ^a   Castillo, F Javier ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c Tedec Meiji Farma SA   (Spain)

Author keywords

Cefditoren; Haemophilus influenzae; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFDITOREN; CEFOTAXIME; CEFTRIAXONE; CEFUROXIME; LEVOFLOXACIN; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL ACTIVITY; ARTICLE; BROTH DILUTION; CONTROLLED STUDY; HAEMOPHILUS INFLUENZAE; HUMAN; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; PRIORITY JOURNAL; SPAIN; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; PNEUMONIA, PNEUMOCOCCAL; RESPIRATORY TRACT INFECTIONS; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 51649111362     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.06.007     Document Type: Article

References (31)

1. Chin N.X., Zhang Y.X., and Neu H.C. In vitro activity of a new cephalosporin ME-1206 compared with other agents. Diagn. Microbiol. Infect. Dis. 14 (1991) 417-424
2. Clark C.L., Nagai K., Dewasse B.E., Pankuch G.A., Ednie L.M., Jacobs M.R., and Appelbaum P.C. Activity of cefditoren against respiratory pathogens. J. Antimicrob. Chemother. 50 (2002) 33-41
3. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically: approved standard. Document M7-A7. 7th ed. (2006), Clinical Laboratory Standards Institute, Wayne, PA
4. Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. Document M100-S18 (2008), Clinical Laboratory Standards Institute, Wayne, PA
5. Felmingham D., Robbins M.J., Ghosh G., Bhogal H., Mehta M.D., Leakey A., Clark S., Dencer C.A., Ridgway G.L., and Gruneberg R.N. An in vitro characterization of cefditoren, a new oral cephalosporin. Drugs Exp. Clin. Res. 20 (1994) 127-147
6. Fenoll A., Robledo O., Lerma M., Gimenez M.J., Cebrian L., Casal J., Aguilar L., and Gomez-Lus M.L. Activity of cefpodoxime and other oral β-lactams against Haemophilus influenzae and Streptococcus pneumoniae with different susceptibilities to penicillin. Rev. Esp. Quimioter. 19 (2006) 39-44
7. Fenoll A., Aguilar L., Robledo O., Gimenez M.J., Tarrago D., Granizo J.J., Gimeno M., and Coronel P. Influence of the β-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media. J. Antimicrob. Chemother. 60 (2007) 323-327
8. Fenoll A., Gimenez M.J., Robledo O., Coronel M., Casal J., and Aguilar L. Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones. Int. J. Antimicrob. Agents 29 (2007) 224-226
9. Fernandez-Roblas R., Lopez J.C., Ramos J.M., Gimeno M., Coronel P., and Soriano F. In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. J. Antimicrob. Chemother. 37 (1996) 1038-1039
10. Fuchs P.C., Barry A.L., and Brown S.D. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria. Diagn. Microbiol. Infect. Dis. 37 (2000) 265-269
11. Garcia-Cobos S., Campos J., Lazaro E., Roman F., Cercenado E., Garcia-Rey C., Perez-Vazquez M., Oteo J., and de A.F. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob. Agents Chemother. 51 (2007) 2564-2573
12. Garcia-de-Lomas J., Garcia-Rey C., Lopez L., and Gimeno C. Susceptibility patterns of bacteria causing community-acquired respiratory infections in Spain: the SAUCE project. J. Antimicrob. Chemother. 50 Suppl S2 (2002) 21-26
13. Johnson D.M., Biedenbach D.J., Beach M.L., Pfaller M.A., and Jones R.N. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species. Diagn. Microbiol. Infect. Dis. 37 (2000) 99-105
14. Jones R.N., Biedenbach D.J., Croco M.A., and Barrett M.S. In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 31 (1998) 573-578
15. Jones R.N., Pfaller M.A., Jacobs M.R., Appelbaum P.C., and Fuchs P.C. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods. Diagn. Microbiol. Infect. Dis. 41 (2001) 1-14
16. Kaczmarek F.S., Gootz T.D., Dib-Hajj F., Shang W., Hallowell S., and Cronan M. Genetic and molecular characterization of β-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother. 48 (2004) 1630-1639
17. Karlowsky J.A., Jones M.E., Draghi D.C., Critchley I.A., Thornsberry C., and Sahm D.F. In vitro susceptibility of recent clinical isolates of pneumococci to the investigational cephalosporin cefditoren. Diagn. Microbiol. Infect. Dis. 42 (2002) 59-64
18. Kelly L.M., Jacobs M.R., and Appelbaum P.C. Comparison of agar dilution, microdilution, E-test, and disk diffusion methods for testing activity of cefditoren against Streptococcus pneumoniae. J. Clin. Microbiol. 37 (1999) 3296-3299
19. Lee M.Y., Ko K.S., Oh W.S., Park S., Lee J.Y., Baek J.Y., Suh J.Y., Peck K.R., Lee N.Y., and Song J.H. In vitro activity of cefditoren: antimicrobial efficacy against major respiratory pathogens from Asian countries. Int. J. Antimicrob. Agents 28 (2006) 14-18
20. Nagai K., Davies T.A., Jacobs M.R., and Appelbaum P.C. Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococci. Antimicrob. Agents Chemother. 46 (2002) 1273-1280
21. Perez-Trallero E., Garcia-de-la-Fuente C., Garcia-Rey C., Baquero F., Aguilar L., Dal-Re R., and Garcia-de-Lomas J. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob. Agents Chemother. 49 (2005) 1965-1972
22. Reinert R.R., Al-Lahham A., and Lutticken R. In vitro activity of cefditoren against clinical isolates of penicillin-susceptible and penicillin-intermediate strains of Streptococcus pneumoniae isolated in Germany, 1992-1998. J. Antimicrob. Chemother. 48 (2001) 279-281
23. Rubio M.C., Goni P., Vergara Y., Seral C., Garcia C., Gomez-Lus P., and Gomez-Lus R. Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents. J. Chemother. 11 (1999) 191-194
24. pc194 and aph(3′)-III genes. Enferm. Infecc. Microbiol. Clin. 18 (2000) 506-511
25. pc194 and the integrase gene of Tn1545 in clinical Streptococcus pneumoniae harbouring erm(B) and mef(A) genes in Spain. J. Antimicrob. Chemother. 47 (2001) 863-866
26. Soriano F., Granizo J.J., Fenoll A., Gracia M., Fernandez-Roblas R., Esteban J., Gadea I., Coronel P., Gimeno M., Rodenas E., and Santos F. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae isolated in four southern European countries (ARISE project) from adult patients: results from the cefditoren surveillance program. J. Chemother. 15 (2003) 107-112
27. Soriano F., Granizo J.J., Coronel P., Gimeno M., Rodenas E., Gracia M., Garcia C., Fernandez-Roblas R., Esteban J., and Gadea I. Antimicrobial susceptibility of Haemophilus influenzae, Haemophilus parainfluenzae and Moraxella catarrhalis isolated from adult patients with respiratory tract infections in four southern European countries. The ARISE project. Int. J. Antimicrob. Agents 23 (2004) 296-299
28. Spangler S.K., Jacobs M.R., and Appelbaum P.C. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other β-lactams. J. Antimicrob. Chemother. 39 (1997) 141-148
29. Tamura A., Okamoto R., Yoshida T., Yamamoto H., Kondo S., Inoue M., and Mitsuhashi S. In vitro and in vivo antibacterial activities of ME1207, a new oral cephalosporin. Antimicrob. Agents Chemother. 32 (1988) 1421-1426
30. Yamada M., Watanabe T., Miyara T., Baba N., Saito J., Takeuchi Y., and Ohsawa F. Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2x: structural basis for its high antimicrobial activity. Antimicrob. Agents Chemother. 51 (2007) 3902-3907
31. Yamaguchi K., Domon H., Miyazaki S., Tateda K., Ohno A., Ishii K., Matsumoto T., and Furuya N. In vitro and in vivo antibacterial activities of CS-834, a new oral carbapenem. Antimicrob. Agents Chemother. 42 (1998) 555-563